Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

1.930 -0.060 (-3.02%)
Streaming Delayed Price Updated: 10:36 AM EST, Feb 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Expert Ratings for GoodRx Holdings ↗
 
Via Benzinga
News headline image
Why Shares of GoodRx Holdings Fell 18.7% Lower This Week ↗
The company, which focuses on delivering prescription drug discounts, has struggled this year. 
Via The Motley Fool
News headline image
2 Growth Stocks Down More Than 50% From Their Highs That Could Be Hot Buys for 2023 ↗
These businesses could perform much better next year. 
Via The Motley Fool
News headline image
Can Doximity Stock Keep On Climbing? ↗
A positive earnings report recently pushed Doximity through the roof, but Investors want to know whether the stock can deliver long-term gains. 
Via The Motley Fool
News headline image
Robinhood, MicroStrategy And Other Big Losers From Wednesday ↗
U.S. stocks closed lower on Wednesday, with the Dow Jones dipping more than 600 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
News headline image
Why GoodRx Stock Was Plunging Today ↗
Revenue continued to slide at the healthcare company. 
Via The Motley Fool
News headline image
GoodRx Holdings, Inc. (GDRX) Q3 2022 Earnings Call Transcript ↗
GDRX earnings call for the period ending September 30, 2022. 
Via The Motley Fool
News headline image
10 Analysts Have This to Say About GoodRx Holdings ↗
Within the last quarter, GoodRx Holdings (NASDAQ:GDRX) has observed the following analyst ratings: 
Via Benzinga
News headline image
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Expert Ratings for GoodRx Holdings ↗
GoodRx Holdings (NASDAQ:GDRX) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Merrimack Pharmaceuticals (NASDAQ:MACK) shares rose 180.0% to $11.2 during Wednesday's pre-market session. The company's market cap stands at $150.1 million. As per the news, the Q3 earnings... 
Via Benzinga
News headline image
GoodRx Reports Third Quarter 2022 Results
From GoodRx Holdings, Inc.
Via Business Wire
News headline image
Where GoodRx Holdings Stands With Analysts ↗
Over the past 3 months, 10 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
News headline image
New Report from GoodRx Shows Positive Impact of Giving Pharmacists the Power to Prescribe
From GoodRx
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022 ↗
Upgrades 
Via Benzinga
News headline image
GoodRx to Present at Upcoming Investor Conferences
From GoodRx Holdings, Inc.
Via Business Wire
News headline image
Should You Buy the Nasdaq's 4 Worst-Performing Stocks of 2022? ↗
These four tech stocks are down nearly 90%. 
Via The Motley Fool
News headline image
Before Pushing Others At Work, Take A Look In The Mirror ↗
Leaders often see their job as driving greatness from others. But the first step is developing your own leadership style. 
Via Investor's Business Daily
News headline image
GoodRx Announces Provider Mode, An Innovative Experience Built Specifically for Healthcare Providers
From GoodRx
Via Business Wire
News headline image
GoodRx and Biogen Collaborate to Help Enhance Enrollment Experience for Providers Who Have Chosen to Start Multiple Sclerosis Patients on VUMERITY®
From GoodRx
Via Business Wire
News headline image
GoodRx Announces Date for Third Quarter 2022 Earnings Release and Conference Call
From GoodRx Holdings Inc.
Via Business Wire
News headline image
Alphabet To $134? Plus This Analyst Slashes Price Target On McDonald's ↗
Credit Suisse cut the price target on Alphabet Inc. (NASDAQ: GOOGL) from $140 to $134. Credit Suisse analyst Stephen Ju maintained an Outperform rating on the stock. Alphabet shares fell 1.2% to $96.69... 
Via Benzinga
News headline image
Where GoodRx Holdings Stands With Analysts ↗
Over the past 3 months, 11 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
News headline image
GoodRx Offers Free Telehealth Appointments to Florida Residents Affected by Hurricane Ian
From GoodRx
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022 ↗
  
Via Benzinga
News headline image
What 14 Analyst Ratings Have To Say About GoodRx Holdings ↗
Over the past 3 months, 14 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022 ↗
Upgrades 
Via Benzinga
News headline image
GoodRx to Present at the Goldman Sachs Communacopia + Technology Conference
From GoodRx Holdings, Inc.
Via Business Wire
< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.